Skip to main content
padlock icon - secure page this page is secure

Free Content Advancing the science in clinical trials for new TB drugs [Editorial]

Download Article:
 Download
(PDF 44.2 kb)
 
No Abstract.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Editorial

Affiliations: 1: Denver Public Health, Denver, Colorado, USA 2: Tibotec, Yardley, Pennsylvania, USA 3: Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA 4: TB Alliance, New York, New York, USA 5: US Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Publication date: 01 February 2008

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more